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ABSTRACT 
The aim of the present study was to evaluate the anticonvulsant effect of whole plant extracts 
of Melissa parviflora using MES and PTZ induced seizures models. The dried whole plant 
was subjected to extraction in methanol and water. The extracts were subjected to phytochem-
ical tests and the carbohydrate, flavonols, coumarins, glycosides and steroid were found to be 
present. The methanolic and aqueous extracts of the plant of Melissa parviflora were observed 
for their anticonvulsant activity by Maximal Electroshock seizures (MES) test and Pentylene-
tetrazole (PTZ) test using Swiss albino mice. Both the extracts showed significant activity in 
MES and PTZ induced convulsions in comparison to control. From the literature surveys as 
well experiments performed, it can be said that Melissa parviflora does pose anticonvulsant 
property. 
 
Keywords: Melissa parviflora, anticonvulsant effects, maximal electroshock, pentylene-
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INTRODUCTION 
Epilepsy is one of the most common se-
rious neurological conditions. In contempo-
rary society, the frequency and importance 
of epilepsy can hardly be overstated from 
the epidemiologic studies. However, in 
most studies, the overall incidence of epi-
lepsy in developed societies has been found 
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to be around 50 cases per 100,000 persons 
per year, and rises steeply in older age 
(Fisher et al., 2005; Poole et al., 2000). It 
affects approximately 50 million people 
worldwide (Fisher et al., 2005). According 
to several publications this can amount to 
70 % of the people with epilepsies, with a 
high prevalence of about 0.8 % in children 
below the age of seven years. The current 
therapeutic treatment of epilepsy with mod-
ern antiepileptic drugs (AEDs) is associated 
with side-effects, dose-related and chronic 
toxicity, and teratogenicity effects, and ap-
proximately 30 % of the patients continue 
to have seizures with current AEDs therapy 
(Samren et al., 1997). 
Natural products from folk remedies 
have contributed significantly in the dis-
covery of modern drugs and can be an al-
ternative source for the discovery of AEDs 
with novel structures and better safety and 
efficacy profiles (Raza et al., 2003). Now, 
various phytochemical and pharmacological 
studies have been carried out on these anti-
convulsant plants (Nsour et al., 2000). 
Herbal medicines are often considered to be 
a gentle and safe alternative to synthetic 
drugs. More than half of the medically im-
portant pharmaceutical drugs are either nat-
ural products or derivatives of natural prod-
ucts (Koehn and Carter, 2005; Newman et 
al., 2003; Sucher, 2006). 
Melissa parviflora belongs to the mint 
family known as Labiatae or Lamiacae. It is 
a pubescent or glabrate, an annual or peren-
nial herb, usually aromatic. It is used for 
heart ailments. It also acts as a tranquillizer 
and has a soothing and calming agent for 
stressed nerves, dyspepsia associated with 
anxiety or depression. It relieves tension 
and stress, and is widely valued for its 
calming properties. It has a tonic effect on 
the heart and circulatory system causing 
mild vasodilation of peripheral vessels, thus 
lowering blood pressure. It may also be 
used in migraine associated with tension, 
neuralgia, anxiety-induced palpitation and 
insomnia. It is useful in liver diseases, hali-
tosis and weakness of eyesight. The plant 
also appears to have an effect on the thyroid 
gland and has been used to treat hyperthy-
roidism (Brauchler et al., 2008). No previ-
ous scientific information has been found 
on its neuropharmacological activity to 
support its use in traditional medicine in 
neuropharmacological situation. The objec-
tive of this study was to provide possible 
pharmacological rationale on the traditional 
use of this plant in the treatment of epilep-
sy. 
 
MATERIALS AND METHODS 
Plant material  
The plant Badranjboya Melissa parvi-
flora was purchased from Shamsi Dawak-
hana, Ballimaran, Delhi-110006, India. The 
authenticity and identity was confirmed on 
the basis of classical description in Unani 
literature at Department of Ilmul Advia F/O 
Medicine (u), Jamia Hamdard, New Delhi 
and modern Botanical information was es-
tablished by matching with the specimens 
available at the National Institute of Sci-
ence Communications. The wealth of Indi-
an division, Dr K. Krishnan Marg, New 
Delhi, 100012. Reference no. of drug sam-
ple NISCAIR/RHMD 1656/254. Voucher 
deposited in D/O Ilmul-Advia F/O Medi-
cine, Jamia Hamdard, New Delhi-110062. 
 
Preparation of extracts 
The whole plant was collected and dried 
at room temperature. After complete dry-
ing, it was powdered and passed through a 
60 mesh sieve and stored in air tight con-
tainer. Dried powdered drug was used to 
prepare extract. 200 g of the powdered 
whole plant drug was taken and extracted 
with water and methanol in a soxhlet appa-
ratus for 72 hrs. The extracts were evapo-
rated to dryness in a rotary flash evaporator 
at a temperature not exceeding 60 °C. Pre-
liminary phytochemical investigations of 
the extract which were conducted as per the 
procedures described by Kokate (Purohit et 
al., 2007) revealed the presence of fla-
vanoids, saponins, carbohydrates, phenolic 
compounds and alkaloids. The dried ex-
tracts (methanolic and aqueous) were pre-
served in desiccators until further use. 
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Animals 
Swiss albino mice of either sex (24-
34 g), supplied by the Central Animal 
House Facility of Jamia Hamdard, New 
Delhi (Registration no. 733/CPCSEA) were 
used. All animals were housed in cages in 
groups of 10, at 23-30 °C with a natural 
light-dark cycle. They had free access to 
standard pellet diet (Amrut Laboratory rat 
and mice feed, Navmaharashtra Chakanoil 
mills Ltd., Pune, India) and tap water. The 
study has been approved by the Ethics 
committee. Ethical norms were strictly fol-
lowed during all experimental procedures. 
 
Determination of acute toxicity 
The acute toxicity studies of methanolic 
and aqueous extract were determined in 
female Swiss albino mice. The animals 
were fasted overnight prior to the experi-
ment. The extracts were administered in 
doses of 50, 300, 1000 and 2000 mg/kg 
b.w. per os (p.o.) to different groups of 
mice each containing 10 animals and mor-
tality were observed after 24 hrs. The meth-
anolic and aqueous extracts of Melissa par-
viflora were devoid of mortality of animals 
at a dose of 2000 mg/kg b.w. in female al-
bino mice by p.o. route (Wang et al., 2007). 
 
Assessment of anticonvulsant activity: 
Maximal Electroshock seizure (MES) 
model: Maximal electroshock seizure mod-
el was used to evaluate the anticonvulsant 
activity of methanolic and aqueous extracts 
orally. Seizures were induced in mice by 
delivering electroshock of 50 mA for 
0.2 sec by means of an electro - convul-
siometer through a pair of ear clip elec-
trodes. The test animals (n=6) received 250, 
500 mg/kg b.w. of methanolic and aqueous 
extracts orally and standard group received 
phenytoin (25 mg/kg b.w.) injected i.p. and 
tested after 30 min for MES induced seizure 
response. All the experimental groups were 
compared with the control treated with ve-
hicle.  
 
PTZ-induced seizures: 
PTZ at the dose of 60 mg/kg b.w. (Min-
imal dose needed to induce convulsions) 
was injected i.p. to induce clonic-tonic con-
vulsions in mice. The test animals (n=6) 
received 250, 500 mg/kg b.w. of methanolic 
and aqueous extracts orally and standard 
group received phenytoin (25 mg/kg b.w.) 
injected i.p. PTZ was injected i.p. 60 min 
after the administration of drugs. Occur-
rence of hind limb tonic extension (HLTE) 
and duration of seizures were noted. If no 
HLTE occurred during the time limit, the 
animals were considered protected. 
 
Statistical analysis: 
The data were analysed using One-way 
analysis of variance (ANOVA) followed by 
Dunnett’s test. P values <0.05 were consid-
ered significant. 
 
RESULTS 
Details of various phytochemical con-
stituents present in different extracts of 
whole plant of Melissa parviflora in which 
the methanolic extract was found to contain 
glycosides and alkaloids and aqueous ex-
tract was found to be rich in glycosides and 
saponins. The anticonvulsant activity of 
methanolic and aqueous extracts at various 
dose levels viz., 250, 500 mg/kg b.w. p. o. 
were studied by the maximum electro-
shock-induced and PTZ seizure models. 
The anticonvulsant activity induced by 
MES model of the methanolic and aqueous 
extracts of Melissa parviflora is shown in 
Table 1, in which the methanolic extract at 
dose level of 500 mg/kg b.wt. elicits signif-
icant activity, though lesser comparable to 
that of phenytoin (standard). Whereas the 
methanolic extract (250 mg/kg b.w.) and 
the aqueous extract (250, 500 mg/kg b.w.) 
also show potent activity but less signifi-
cant than the methanolic extract. 
In PTZ induced seizures, the admin-
istration of Melissa parviflora methanolic 
and aqueous extracts at doses of 250 and 
500 mg/kg b.w. 1 hr prior to the injection of 
PTZ, significantly (p<0.05) delayed the on-
set of convulsions as shown in Table 2. 
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Phenytoin in a dose of 25 mg/kg b.w. total-
ly abolished the episodes of convulsions. 
 
Table 1: Effect of methanolic and aqueous ex-
tracts of Melissa parviflora on hind limb exten-
sion induced by MES in mice 
 
Group  
 
Dose 
(mg/kg) 
 
Hind limb 
extension 
(Mean ± SE) 
 
Control 10   11.30 ± 1.43 
Phenytoin 25 0.50 ± 0.28* 
MEMP 250 5.16 ± 0.65* 
MEMP 500 4.16 ± 0.47* 
AAMP 250 6.33 ± 0.49* 
AAMP 500 5.33 ± 0.61* 
Values are expressed as mean ± SE (n=6); 
*p<0.05, as compared to control 
 
Table 2: Effect of methanolic and aqueous ex-
tracts of Melissa parviflora on PTZ induced sei-
zures in mice 
 
Group Dose 
(mg/kg) 
 
Onset 
Time (sec) 
 Duration of   
 HLTE (sec) 
 
Control 10   51.81±0.11 36.70±0.49 
Phenytoin 25                 0*   0* 
MEMP 250 54.85±0.11* 32.33±0.89* 
MEMP 500 64.70±0.12* 20.81±0.75* 
AAMP 250 53.85±0.10* 35.08±0.56* 
AAMP 500 57.85±0.16* 30.28±0.54* 
Values are expressed as mean ± SE (n=6); 
*p<0.05, as compared to control 
 
DISCUSSION 
Mental, neurological and behavioral 
disorders are common to all countries and 
cause immense suffering. People with these 
disorders are often subjected to social isola-
tion, poor quality of life, and increased 
mortality. These disorders are the cause of 
staggering economic and social costs. Ha-
bituation, dependence and the resulting po-
tential for addiction are the greater disad-
vantages of the modern synthetic psycho-
pharmacological agents. The abrupt discon-
tinuation of long-term therapy with these 
drugs leads to serious withdrawal symp-
toms. Therefore, modern society is now 
cautiously discovering traditional herbal 
medicines, particularly those which have 
been proved to be effective in controlled 
studies and which in some cases demon-
strated even better galenic properties than 
the conventional medicines. Unique oppor-
tunities for research exist in the field of 
CNS-active Indian medicinal plants (Weiss 
and Fintelmann, 2000). Pharmacological 
evaluation of the anticonvulsant properties 
of the aqueous and methanolic extracts of 
Melissa parviflora against PTZ induced 
seizure revealed that both the methanolic 
and aqueous extracts exhibited statistically 
significant and dose dependent delay in the 
onset of seizure; both extracts showed sig-
nificant and dose dependent reduction in 
the duration of HLTE. However, the meth-
anolic extract was more active against PTZ 
induced convulsion than the aqueous ex-
tract. On the other hand, both extracts 
showed significant and dose dependent re-
duction of the HLTE induced by MES and 
PTZ. Data from the literature show that the 
efficiency of different extracts varies large-
ly probably due to the final composition of 
phytochemicals (Thirupathy et al., 2011). 
But in our case there was not much differ-
ence between the methanolic and aqueous 
extracts of Melissa parviflora. 
MES and PTZ may be exerting their 
convulsant effects by inhibiting the activity 
of gamma amino butyric acid (GABA) at 
GABA-A receptors (De Sarro et al., 1999; 
Vijayalakshmi et al., 2011). Gamma amino 
butyric acid is the major inhibitory neuro-
transmitter which is implicated in epilepsy. 
The enhancement and inhibition of the neu-
rotransmission of GABA will attenuate and 
enhance convulsion, respectively (De Sarro 
et al., 1999; Quintans-Junior et al., 2008). 
Pentylenetetrazole is an antagonist of 
GABA at GABA receptor which has been 
widely implicated in epilepsy (Enna, 2007; 
Mishra et al., 2011; Vogel, 2002). Further-
more; drugs which protect animals against 
the generalized clonic seizure induced by 
PTZ are effective in protection and man-
agement of petit mal epilepsy (Czuczwar et 
al., 1990). MES induced seizure can be 
prevented either by drugs that inhibit volt-
age gated sodium channel such as phenyto-
in or by drugs that inhibit glutaminergic 
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excitation mediated by NMDA receptors 
such as felbamate (Mishra et al., 2011). 
This implies that Melissa parviflora may be 
effective as an anticonvulsant medicinal 
plant and its anticonvulsant effect my in-
volve Gabergic inhibitory and glutaminer-
gic excitatory mechanisms or inhibition of 
the voltage gated sodium channel (Löscher 
et al., 1996). Phytochemical screening of 
the plant showed that the plant contains al-
kaloids, flavonoids, sterols, glycosides and 
saponins, to which the anticonvulsant activ-
ity of the plant extracts may be attributed.  
 
CONCLUSION 
In conclusion, Melissa parviflora ex-
tracts may have potential anticonvulsant 
activity which may be due to the presence 
of certain active phytoconstituent. The anti-
convulsant activity of Melissa parviflora 
may involve gabaergic transmission and 
glutaminergic transmission or sodium 
channel blockage. Further studies are, how-
ever, needed to isolate the active princi-
ple(s) of the plant and to enlighten the 
mechanism underlying its anticonvulsant 
effect. To this end we have to perform stud-
ies that will elucidate the exact mechanism 
of action of these active principle(s) before 
recommending these extracts for clinical 
application. 
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